GLIBA
GCI Liberty, Inc.
GLIBA's fundamentals are mixed. Its PE isn't a useful guide right now because of how its recent earnings were reported.
NBIS
Nebius Group N.V.
There isn't enough reported data to score NBIS yet.
GLIBA Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| Stable | |
| Stable |
GLIBA's profitability is currently healthy, and its cash flow and balance sheet are stable. There isn't enough data to rate its revenue.
NBIS Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| Unavailable | |
| Healthy |
NBIS's profitability and balance sheet are currently healthy. There isn't enough data to rate its revenue and cash flow.
GLIBA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 7.7x | $28.29 | — |
| Cheap | 14x | N/A | N/A |
| Fair | 14x | N/A | N/A |
| Expensive | 15x | N/A | N/A |
| Current | 15x | $28.29 | — |
Historical ranges are pointers, not guarantees.
GLIBA's PE is 15x, but its earnings don't support one, so it isn't a reliable read right now.
NBIS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 68x | $22.45 | -83% |
| Fair | 114x | $37.67 | -71% |
| Current | 390x | $129 | — |
| Expensive | 666x | $220 | +71% |
Historical ranges are pointers, not guarantees.
NBIS's PE is 390x, but its earnings don't support one, so it isn't a reliable read right now.
GLIBA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Decline | |
| Growth | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect GLIBA's revenue to grow, but its earnings and profitability to decline.
NBIS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
NBIS has the edge over GLIBA on the outlook, with more favorable earnings and profitability expectations.
GLIBA Earnings Per Share
GLIBA and NBIS do not have enough comparable growth data to identify a winner.
NBIS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | $0.33 | +$2.61 |
| Q4 2024 | -$2.28 | -456% |
| Q4 2023 | $0.64 | -36% |
| Q4 2022 | $1.00 | +$1.49 |
| Q4 2021 | -$0.49 | -156% |
| Q4 2020 | $0.87 | +89% |
| Q4 2019 | $0.46 | -73% |
| Q4 2018 | $1.71 | +434% |
NBIS has returned to profit: it earned $0.33 per share over the past year, after losing money the year before.
GLIBA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267M | +3.9% |
| Q2 2026 | $261M | 0% |
| Q1 2026 | $256M | -3.8% |
GLIBA has the edge over NBIS in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 13% | +203 points |
| Q2 2026 | 11% | -8.4 points |
| Q1 2026 | 12% | -10 points |
| Q4 2025 | 12% | N/A |
| Q3 2025 | -190% | N/A |
| Q2 2025 | 20% | N/A |
| Q1 2025 | 22% | N/A |
GLIBA's operating margin was 13% last quarter, up 203 points from the same quarter a year ago.
NBIS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2023 | $9.7B | +53% |
| Q4 2022 | $6.3B | +46% |
| Q4 2021 | $4.3B | +63% |
| Q4 2020 | $2.6B | +24% |
| Q4 2019 | $2.1B | +37% |
| Q4 2018 | $1.5B | +36% |
| Q4 2017 | $1.1B | +24% |
| Q4 2016 | $917M | +27% |
NBIS's revenue is growing: $530M last quarter, down 80% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -115% | -112 points |
| Q4 2023 | 3.6% | -11 points |
| Q4 2022 | 2.5% | -14 points |
| Q4 2021 | -3.7% | -18 points |
| Q4 2020 | 7.4% | -9.5 points |
| Q4 2019 | 14% | -2 points |
| Q4 2018 | 16% | -14 points |
| Q4 2017 | 14% | -19 points |
NBIS's operating margin was −115% last quarter, down 123 points from the same quarter a year ago, near the bottom of its range since 2011.
GLIBA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2M | -90% |
| Q1 2026 | $22M | -59% |
GLIBA and NBIS do not have enough comparable growth data to identify a winner.
NBIS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$3.7B | -$3.1B |
| Q4 2024 | -$562.1M | -$316.2M |
| Q4 2023 | -$245.9M | -$138.9M |
| Q4 2022 | -$107M | +$319.7M |
| Q4 2021 | -$426.7M | -539% |
| Q4 2020 | $97.3M | -66% |
| Q4 2019 | $287.9M | +$289.2M |
| Q4 2018 | -$1.3M | -101% |
NBIS has burned cash in six of the last eight quarters: −$4.6B over the past year, against −$43M the year before.
GLIBA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | +39% | +11.3M shares |
GLIBA has 40M diluted shares, up 39% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
NBIS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -12% | -33.3M shares |
| 1 year | -32% | -115M shares |
| 3 years | -26% | -86.9M shares |
NBIS has the edge over GLIBA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2024 | $10M |
| Q4 2021 | $84.1M |
| Q4 2020 | $122.8M |
| Q4 2019 | $17.2M |
| Q4 2018 | $121.8M |
| Q4 2014 | $101.7M |
| Q4 2013 | $102.9M |
GLIBA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.1x | Moderate |
GLIBA's net debt is about 2.1 years of its operating earnings (EBITDA).
NBIS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2023 | 0.7x | Very low |
| Q4 2022 | -0.7x | Net Cash |
NBIS's net debt is less than a year of its operating earnings (EBITDA).
GLIBA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.4 | Neutral |
| Stochastic | 71.6 | Neutral |
GLIBA's weekly RSI is 58 (neutral) and its Stochastic is 72 (neutral).
NBIS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 8.3 | Oversold |
NBIS's weekly RSI is 38 (neutral) and its Stochastic is 8 (oversold).
GLIBA PE vs Communication Services Sector
NBIS PE vs Communication Services Sector
| Metric | NBIS | Sector median | Relative |
|---|---|---|---|
| PE | 390x | 16x | 2,264% above |
| PE % | 62 | 24 | 38 pts above |
NBIS is trading at 390x earnings, a 2264% premium to the Communication Services sector's median of 16x, though its earnings don't support one.
GLIBA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $23.2 | 22% above |
| 20 week MA | $24.0 | 18% above |
| 50 week MA | $29.6 | 4.3% below |
GLIBA has stronger trend alignment. GLIBA is above 2 of 3 weekly averages versus NBIS above 1 of 4.
NBIS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $179.7 | 28% below |
| 20 week MA | $199.9 | 36% below |
| 50 week MA | $163.5 | 21% below |
| 100 week MA | $110.0 | 17% above |
NBIS has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 17% above its 100-week average.
GLIBA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $32.5 | $36.0 | +11% |
| 2026 YTD | $36.0 | $28.3 | -21% |
GLIBA has finished every year since 2025 higher, and it's down 21% so far in 2026.
NBIS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $19.6 | $27.3 | +40% |
| 2025 | $27.3 | $87.6 | +221% |
| 2026 YTD | $87.6 | $128.6 | +47% |
NBIS has the edge over GLIBA on returns for 2026, with the stronger performance.